跳至主要内容
临床试验/KCT0004994
KCT0004994招募中未知

The effect of mosapride in patients with small intestinal bacterial overgrowth: A randomized, prospective, double-blind clinical trial

The Catholic University of Korea, St. Vincent's Hospital0 个研究点目标入组 87 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
87

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 80(Year)(—)
性别
All

入选标准

  • 1) patients of age 20 to 80
  • 2) patients diagnosed with small intestinal bacterial overgrowth in the glucose breath test

排除标准

  • 1) Patients who were treated with antibiotics within 3 months
  • 2) Patients diagnosed with gastrointestinal stricture or obstruction at the endoscopy or upper gastrointestinal series
  • 3) Patients with previous gastrointestinal surgery, except for appendectomy
  • 4) Patients who have gastrointestinal bleeding, mechanical obstruction, or perforation
  • 5) Patients who have severe organ dysfunction, such as renal dysfunction or hepatic dysfunction
  • 6) Patients who were treated with medication, such as prokinetics, histamine receptor antagonists, proton pump inhibitors, anticholinergics, antidepressant within 2 weeks before the study
  • 7) Allergic reaction for experimental medicine
  • 8) Improper patient in the study, according to judgement of researcher

研究者

发起方
The Catholic University of Korea, St. Vincent's Hospital

相似试验